NCT05502250 2026-03-06
HOVON164HL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT05977673 2025-12-08
FIL_Tisle-HL
Fondazione Italiana Linfomi - ETS
Phase 2 Recruiting
NCT06761911 2025-01-07
BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma
Dalian Medical University
Phase 4 Not yet recruiting
NCT05627115 2023-11-29
RATiFY
University College, London
Phase 2 Not yet recruiting
NCT04843267 2021-04-13
A Multi-center, Non-randomized, Open-label Phase II Clinical Study on the Treatment of Newly Diagnosed Advanced Hodgkin's Lymphoma With PD-1 Antibody (Tislelizumab) Combined With AVD Regimen (Doxorubicin, Vindesine, Dacarbazine) Under the Guidance of PET/CT
Sun Yat-sen University
Phase 2 Unknown